1: Home (ALT-H)
2: HMA Joint (ALT-M)
3: Human Medicines (ALT-U)
- 3.1: Heads of Agencies (ALT-E)
- 3.2: CMD(h) (ALT-C)
- 3.3: MRI Product Index (ALT-R)
- 3.4: Directory (ALT-I)
4: Veterinary Medicines (ALT-V)

You are here: Human Medicines > CMD(h) > About CMDh

3.2.1: About CMDh (ALT-O)
- 3.2.1.1: CMDh composition (ALT-P)
- 3.2.1.2: CMDh Activities (ALT-T)
- 3.2.1.3: CMDh Workplan (ALT-W)
- 3.2.1.4: CMDh Reports (ALT-S)
- 3.2.1.5: Contacts with Representative Organisations (ALT-N)
- 3.2.1.6: Transparency Measures (ALT-Y)
- 3.2.1.7: Calendar for CMDh meetings (ALT-L)
- 3.2.1.8: MRFG (1995-2005) (ALT-G)
3.2.2: Statistics
3.2.3: Press Releases
3.2.4: Procedural Guidance
3.2.5: CMDh-Referrals
3.2.6: Product Information
3.2.7: Advice from CMDh
3.2.8: Templates
3.2.9: CMD subgroups / working groups (ALT-K)
3.2.10: Paediatric Regulation
3.2.11: Questions & Answers (ALT-Q)
3.2.12: Contact Form
3.2.13: Contact Points
3.2.14: What's new history

About CMDh

CMDh Composition Click here

CMDh Activities Click here

CMDh Workplan Click here

CMDh Reports Click here

Contact with Representatives Organisations Click here

Transparency Measures Click here

Calendar for CMDh Click here

MRFG (1995-2005) Click here